Bank Pictet & Cie (Europe)’s HCA Healthcare HCA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q4 | – | Sell |
-1,325
| Closed | -$326K | – | 276 |
|
2023
Q3 | $326K | Sell |
1,325
-18
| -1% | -$4.43K | 0.01% | 209 |
|
2023
Q2 | $408K | Sell |
1,343
-74
| -5% | -$22.5K | 0.01% | 200 |
|
2023
Q1 | $374K | Buy |
1,417
+11
| +0.8% | +$2.9K | 0.02% | 142 |
|
2022
Q4 | $337K | Buy |
+1,406
| New | +$337K | 0.02% | 139 |
|
2021
Q1 | – | Sell |
-1,637
| Closed | -$269K | – | 185 |
|
2020
Q4 | $269K | Sell |
1,637
-202
| -11% | -$33.2K | 0.01% | 140 |
|
2020
Q3 | $229K | Buy |
+1,839
| New | +$229K | 0.01% | 121 |
|
2020
Q1 | – | Sell |
-2,757
| Closed | -$408K | – | 156 |
|
2019
Q4 | $408K | Sell |
2,757
-305
| -10% | -$45.1K | 0.06% | 120 |
|
2019
Q3 | $369K | Hold |
3,062
| – | – | 0.06% | 131 |
|
2019
Q2 | $414K | Hold |
3,062
| – | – | 0.07% | 120 |
|
2019
Q1 | $399K | Sell |
3,062
-1,003
| -25% | -$131K | 0.07% | 113 |
|
2018
Q4 | $506K | Sell |
4,065
-1,439
| -26% | -$179K | 0.1% | 78 |
|
2018
Q3 | $766K | Sell |
5,504
-1,185
| -18% | -$165K | 0.11% | 86 |
|
2018
Q2 | $686K | Buy |
6,689
+235
| +4% | +$24.1K | 0.11% | 84 |
|
2018
Q1 | $626K | Buy |
6,454
+468
| +8% | +$45.4K | 0.1% | 83 |
|
2017
Q4 | $526K | Sell |
5,986
-3,691
| -38% | -$324K | 0.07% | 113 |
|
2017
Q3 | $770K | Hold |
9,677
| – | – | 0.11% | 122 |
|
2017
Q2 | $844K | Buy |
9,677
+2,357
| +32% | +$206K | 0.12% | 125 |
|
2017
Q1 | $651K | Sell |
7,320
-417
| -5% | -$37.1K | 0.09% | 127 |
|
2016
Q4 | $573K | Sell |
7,737
-450
| -5% | -$33.3K | 0.1% | 116 |
|
2016
Q3 | $619K | Sell |
8,187
-1,089
| -12% | -$82.3K | 0.11% | 106 |
|
2016
Q2 | $714K | Hold |
9,276
| – | – | 0.15% | 87 |
|
2016
Q1 | $724K | Buy |
9,276
+722
| +8% | +$56.4K | 0.14% | 85 |
|
2015
Q4 | $579K | Buy |
8,554
+1,100
| +15% | +$74.5K | 0.11% | 100 |
|
2015
Q3 | $577K | Buy |
7,454
+794
| +12% | +$61.5K | 0.13% | 105 |
|
2015
Q2 | $604K | Buy |
+6,660
| New | +$604K | 0.6% | 55 |
|